2016
Patient survival, predictive factors and disease course of severe sepsis in Czech intensive care units: a multicentre, retrospective, observational study
UVIZL, Radovan; Milan ADAMUS; Vladimir CERNY; Ladislav DUŠEK; Jiří JARKOVSKÝ et al.Základní údaje
Originální název
Patient survival, predictive factors and disease course of severe sepsis in Czech intensive care units: a multicentre, retrospective, observational study
Autoři
UVIZL, Radovan; Milan ADAMUS; Vladimir CERNY; Ladislav DUŠEK; Jiří JARKOVSKÝ ORCID; Vladimír ŠRÁMEK; Martin MATEJOVIC; Petr ŠTOURAČ; Roman KULA; Jan MALÁSKA a Pavel SEVCIK
Vydání
Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Palacký University, 2016, 1213-8118
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 0.894
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/16:00089692
Organizační jednotka
Lékařská fakulta
UT WoS
000379360500017
EID Scopus
2-s2.0-84976428009
Klíčová slova anglicky
severe sepsis; septic shoc; lactate; mortality; assessment
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 25. 8. 2016 12:43, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Background. Severe sepsis/septic shock is associated with high mortality. In Central Europe, there is a dearth of information on the prevalence and treatment of severe sepsis. The EPOSS (Data-based Evaluation and Prediction of Outcome in Severe Sepsis) project launched in 2011 was aimed at collecting data on patients with severe sepsis/septic shock. Methods. The EPOSS study processes data from the EPOSS project database, and is a retrospective, multicentre, observational study. This included all consecutive patients aged 18 and over who were admitted to participating ICUs from 1 January 2011 to 5 November 2013 and met the inclusion criteria of severe sepsis/septic shock. The primary endpoint was to analyse the relationship between in-hospital mortality (either in ICU or after discharge from ICU) and the type and number of fulfilled diagnostic and treatment interventions during the first 6 h after the diagnosis of severe sepsis/septic shock. Results. The collected dataset involved 1082 patients meeting the criteria of severe sepsis/septic shock. Following data validation, a final dataset of 897 patients was obtained. The average age of the patient group was 64.7 years; mortality at discharge from EPOSS ICUs was 35.5% and from hospital 40.7%. Of the 10 evaluated diagnostic and treatment interventions within the initial 6 hours of identifying severe sepsis/septic shock (i.e. fulfilment of SSC bundles), four or five diagnostic and treatment interventions were administered to 58.4% patients. Combined diagnostic and treatment interventions associated with the lowest in-hospital mortality were: CVP of >= 8-12 mm Hg & MAP of >= 65 mm Hg & Urine output at >= 0.5 mL/kg/h & Lactate of <= 4.0 mmol/L & Initial lactate measured & Antibiotics in the first hour. Lactate at <4 mmol/L and MAP of >= 65 mm Hg remained statistically significant even after adjustment for patient age and APACHE II score. Statistically significantly increased in-hospital mortality was found in patients admitted from general departments (45.7%) or from other ICUs (41.6%), compared to a lower in-hospital mortality of patients transferred from outpatient clinics (26.5%) or Emergency (38.0%). Severe sepsis/septic shock patients transferred from the department of internal medicine were associated with a higher in-hospital mortality (45.1%) than surgical patients (35.5%). Conclusions. The most effective measures associated with the lowest in-hospital mortality in septic shock patients were CVP of >= 8-12 mm Hg, MAP of >= 65 mm Hg, urine output at >= 0.5 mL/kg/h, initial lactate level of <= 4.0 mmol/L and administration of antibiotics within the first hour.